The Effect of the Nutraceutical "Hemofix" on the Coagulation System

Hadassah Medical Center

Status: Withdrawn

Conditions: Von Willebrand Disease; Menorrhagia

Treatments: Dietary Supplement: HEMOFIX

Study type: Interventional

Funder types: Other

Identifiers

NCT01651468

HEMOFIX- HMO-CTIL

Details and patient eligibility

About

Hemofix is a herbal formula based on traditional Jewish and far eastern medicine created to assist in wound healing and bleeding arrest. It contains herbs such as Red Clover, Liquorice, Raspberry, Ginger and more. The present study will evaluate the formula on the coagulation system.

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteers and volunteers with a mild bleeding disorder

Exclusion criteria

• people with thrombophilic and cardiovascular complications,
• people who are treated with anti-coagulants,
• women taking birth control pills
• people with a history hypercoagulability

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

HEMOFIX

Experimental group

Description:

3 grams a day

Treatment:

Dietary Supplement: HEMOFIX